Haleon plc Form 6-K Summary
Business context and reporting period
Haleon plc filed this Form 6-K for March 2023 on March 20, 2023. The filing announces the publication of the company’s 2022 Annual Report and Form 20-F, together with materials for the 2023 Annual General Meeting. Haleon is a global consumer-health company operating across oral health, pain relief, respiratory health, digestive health, other health products, and vitamins, minerals and supplements.
Financial information
This Form 6-K announcement does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics. It states that the 2022 Annual Report and Form 20-F contain the complete audited financial statements.
Material changes versus the prior comparable period
The filing text does not describe material year-over-year changes. Any comparison with prior periods must be obtained from the 2022 Annual Report and Form 20-F.
Guidance, outlook, risks, contingencies, and unusual items
The filing does not provide guidance, management outlook, risk updates, contingencies, or unusual-item disclosures. It is primarily an announcement regarding the availability and filing of annual reporting and AGM materials.
Investor verification items
- Review the 2022 Annual Report and Form 20-F for audited financial statements and key performance metrics.
- Verify reported revenue, profitability, cash flow, margins, debt, liquidity, and comparative 2021 figures in the annual report.
- Review the annual report’s risk factors, contingencies, accounting judgments, and management outlook.
- Review the 2023 AGM notice, proxy materials, and voting instruction card for matters requiring shareholder approval.
- Confirm the filing and related documents through the SEC, the UK National Storage Mechanism, or Haleon’s website.